CTRI/2024/01/061920已完成3 期
A Prospective, Multi-Arm, Open-Label, Singl-Centre Clinical Study to Evaluate the Safety and Efficacy of Surabhi Saara in Patients with Diabetes, Varicose Veins, PCOD, Ulcers and Acidity - NI
Surabhi Pharmaceuticals0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Arm A ( Diabetes )
- •1.Patients with Type 1 and Type 2 Diabetes
- •2.Cases which are already diagnosed and who are on other systems of medicine treatment will also be taken into consideration.
- •Arm B (Varicose Vein)
- •1.Patients with unilateral and bilateral varicose vein in the lower limbs
- •2.Diagnosed case of varicose vein in lower limb
- •Arm C (Polycystic Ovarian Disease)
- •1.Female patients of age between 20-35years
- •2.USG pelvis showing polycystic ovaries
- •3.Irregular menstrual cycle: Eight or fewer menstrual cycles in the past year or inter menstrual periods of 45 days or longer
- •Arm D (Mouth ulcers)
- •1.Patients with sores or erosion in the inner lining of mouth
- •2.Cases which are already diagnosed and who are on other systems of medicine treatment will also be taken into consideration.
- •Arm E (Acidity)
- •1.Patients exhibiting signs of Acidity (pH test is done to detect the same)
排除标准
- •Arm A (Diabetes)
- •1.Pregnant and lactating mothers
- •2.Severe cases of Diabetes
- •Arm B ( Varicose Vein)
- •1.Patients with the bleeding disorders
- •Arm C (Polycystic Ovarian Disease)
- •1.PCOD cases with severe Systemic illness
- •2.Pregnant and lactating mothers
- •Arm D and Arm E (Mouth ulcers and Acidity)
- •1.Chronic alcoholics and Habitual Tobacco chewers
- •2.Subjects with chronic immune diseases like HIV
研究者
相似试验
已完成
4 期
Post Marketing Observational Study to Assess the Effectiveness and Safety of Prochlorperazine In Patients with Acute VertigoCTRI/2022/01/039287Abbott Healthcare Pvt Ltd
招募中
Unknown
To assess the efficacy, safety and tolerability of CELNUTRA 2.0 and Kitchen feed in the Intensive Care Unit PatientsCTRI/2023/05/052938ucgenex lifesciences Pvt. Limited
进行中（未招募）
1 期
A clinical trial to study the effects of selexipag on the heart in patients with Pulmonary Arterial HypertensioMedDRA version: 21.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary Arterial HypertensionEUCTR2019-004783-22-FRACTELION Pharmaceuticals Ltd.80
已完成
4 期
A Prospective, Multicenter, Single-Arm, Open-Label, Phase 4 Study of the Effects of Selexipag on Right Ventricular Remodeling in Pulmonary Arterial Hypertension Assessed by Cardiac Magnetic Resonance Imaging. (RESTORE)pulmonary arterial hypertensionPAHNL-OMON52455Actelion Pharmaceuticals5
进行中（未招募）
1 期
A clinical trial to study the effects of selexipag on the heart in patients with Pulmonary Arterial HypertensioMedDRA version: 21.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary Arterial HypertensionEUCTR2019-004783-22-NLACTELION Pharmaceuticals Ltd.80